Something is brewing that's for sure.
For RGC and cortina boy coming up all guns blazing, it makes me as excited as an upcoming announcement.
CB - not wrong on needing to get through phase II, but lets not cloud people's perspective on the requirements to get through phase II.
Every trial is different. Each drug is different and in NEU's case the end points are more forgiving than many others that have fallen at this stage.
Big difference between curing a disease and improving outcomes, but lets not go down that old trodden path of end points again.
Your persistent referral to past statistics is stale and relevant only to the trials that make up those statistics.
Looks like we are set for a run.
bell potters no 1 biotech, page-30
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.13 |
Change
0.020(0.15%) |
Mkt cap ! $1.678B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.44 | $13.07 | $5.021M | 378.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 11501 | $13.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.18 | 1539 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |